Q2 EPS Estimates for ArriVent BioPharma Cut by HC Wainwright

ArriVent BioPharma, Inc. (NASDAQ:AVBP – Free Report) – Research analysts at HC Wainwright reduced their Q2 2025 earnings per share estimates for shares of ArriVent BioPharma in a report released on Wednesday, May 14th. HC Wainwright analyst R. Burns now antic…

Read Full Article →